Pentostatin in chronic lymphocytic leukemia

Expert Opinion on Drug Metabolism & Toxicology
Craig SauterMark A Weiss

Abstract

Chronic lymphocytic leukemia (CLL) is a disease that typically afflicts older individuals with a median age of diagnosis in the eighth decade of life for which treatments available now are not curative. Although purine analogue based combinations produce complete responses (CRs) in many patients, the use of these combinations has been limited by toxicity including myelosuppression and an increased risk of infectious complications. To identify the role of pentostatin, a specific inhibitor of adenosine deaminase (ADA), in the treatment of CLL. We compare pentostatin to other purine analogues, most notably fludarabine, with regard to safety and efficacy. Finally, we review the use of pentostatin in other diseases. The scope of this review encompasses the history of treatment for CLL as well as the genesis of modern combination chemoimmunotherapy and the advantages of pentostatin within such a treatment program. Combination therapy with pentostatin seems to provide response frequencies comparable to fludarabine based combinations but with less toxicity and with greater ease of administration.

References

Jan 1, 1979·Advances in Experimental Medicine and Biology·R M PaineK R Harrap
May 1, 1975·British Journal of Cancer·J F Smyth, K R Harrap
Jan 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J KeatingK B McCredie
Apr 2, 1987·The New England Journal of Medicine·A S SpiersM J O'Connell
Feb 1, 1985·The Journal of Clinical Investigation·S SetoD A Carson
Feb 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E H KrautM R Grever
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R O DillmanO R McIntyre
Sep 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R GreverS P Balcerzak
Mar 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Montserrat, C Rozman
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SavenL D Piro
Jun 1, 1997·Journal of the American Academy of Dermatology·D GreinerG Petroni
Jan 22, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A D HoR Zittoun
Dec 15, 2000·The New England Journal of Medicine·K R RaiC A Schiffer
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S M O'BrienM Keating
Oct 23, 2002·The Hematology Journal : the Official Journal of the European Haematology Association·Tadeusz RobakDariusz Wołowiec
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A WeissDenise Horgan
Jun 5, 2003·British Journal of Haematology·Andrew R Pettitt
Apr 24, 1958·Annals of the New York Academy of Sciences·C A DOANB A BOURONCLE
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William WierdaMichael Keating
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javier Bolaños-MeadeGeorgia B Vogelsang
Mar 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicole LamannaMark A Weiss
Sep 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David A JacobsohnGeorgia B Vogelsang

❮ Previous
Next ❯

Citations

Jul 19, 2013·Future Medicinal Chemistry·Rodrigo G DucatiVern L Schramm
Jun 22, 2013·Leukemia Research·Joshua Lukenbill, Matt Kalaycio
Dec 7, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jacopo MariottiDaniel H Fowler
Dec 3, 2011·Nucleosides, Nucleotides & Nucleic Acids·Paula X Fernández-CalottiMarçal Pastor-Anglada
Sep 15, 2019·International Journal of Biological Macromolecules·S BagheriT Haertlé
Jan 8, 2021·Behavioural Brain Research·Xiaonan ZhangShengming Yin
Feb 28, 2021·Drug Discovery Today·Shuli ManLong Ma

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.